Cerebrospinal fluid cfDNA-based molecular assessment of resection extent and prognosis in glioma
These findings suggest that CSF cfDNA effectively represents the genetic profile of gliomas and serves as a sensitive measure for surgical resection efficacy and patient prognosis, highlighting its potential as a non-invasive biomarker for enhancing post-operative management in glioma patients.
Authors
- Longbo Zhang (ORCID: https://orcid.org/0000-0002-6217-6066)
- Shuwen Kuang
- Shifu Li
- Kang Xie
- Zhiqiang Liu
- Chao Liu
- Tianxiang Huang
- Ying Wang
- Jun Wu
- Jian Zhen Yu
Institutions
- Central South University (CN)
- Erasmus MC (NL)
- National Clinical Research (US)
- Xiangya Hospital Central South University (CN)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- Communications Medicine
- Published
- 2026-02-02
- DOI
- https://doi.org/10.1038/s43856-026-01386-z
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Distinguished Young Scholar Foundation of Hunan Province